This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-08-3559v1 69/4/1279    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hurst, D. R. Articles by Welch, D. R. Search for Related Content PubMed PubMed Citation Articles by Hurst, D. R. Articles by Welch, D. R.

Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis

Departments of ¹ Pathology, ² Cell Biology, and ³ Pharmacology/Toxicology, ⁴ Comprehensive Cancer Center, and ⁵ National Foundation for Cancer Research, Center for Metastasis Research, University of Alabama at Birmingham, Birmingham, Alabama and ⁶ Buck Institute for Age Research, Novato, California

Requests for reprints: Danny R. Welch, Department of Pathology, University of Alabama at Birmingham, 1670 University Boulevard, Room VH-G019, Birmingham, AL 35294-0019. Phone: 205-934-2961; Fax: 205-975-1126; E-mail: DanWelch{at}uab.edu.

Key Words: Metastasis suppression • microRNA • BRMS1 • EGFR • NF-B

Breast cancer metastasis suppressor 1 (BRMS1) is a predominantly nuclear protein that differentially regulates expression of multiple genes, leading to suppression of metastasis without blocking orthotopic tumor growth in multiple human and murine cancer cells of diverse origins. We hypothesized that miR-146 may be involved in the ability of BRMS1 to supress metastasis because miR-146 expression is altered by BRMS1 and because BRMS1 and miR-146 are both associated with decreased signaling through the nuclear factor-B pathway. BRMS1 significantly up-regulates miR-146a by 6- to 60-fold in metastatic MDA-MB-231 and MDA-MB-435 cells, respectively, and miR-146b by 40-fold in MDA-MB-435 as measured by real-time quantitative reverse transcription-PCR. Transduction of miR-146a or miR-146b into MDA-MB-231 down-regulated expression of epidermal growth factor receptor, inhibited invasion and migration in vitro, and suppressed experimental lung metastasis by 69% and 84%, respectively (mean ± SE: empty vector = 39 ± 6, miR-146a = 12 ± 1, miR-146b = 6 ± 1). These results further support the recent notion that modulating the levels of miR-146a or miR-146b could have a therapeutic potential to suppress breast cancer metastasis. [Cancer Res 2009;69(4):1279–83]

This article has been cited by other articles:

				D. R. Hurst, M. D. Edmonds, and D. R. Welch Metastamir: The Field of Metastasis-Regulatory microRNA Is Spreading Cancer Res., October 1, 2009; 69(19): 7495 - 7498. [Abstract] [Full Text] [PDF]